One report proved that osteopontin promotes the progression of hepatocellular carcinoma (HCC) via stimulating the PI3K/AKT/Twist signaling pathway, contributing to the enhancement of EMT [90]. Here, TWIST1 is linked to hepatocellular carcinoma.